People | Eramol
Let's Talk

People

Eramol was created by Eric Che and Peter Mollison.

Eric and Peter embrace challenges with an inspired and forward-thinking approach. Eramol was founded on the shared values of the co-founders to offer a tailored and responsive clinical trial manufacturing services to sponsors with a wide set of requirements. 

Eric Che

Eric has worked in the pharmaceutical sector for over 15 years, since completing his pharmacist training in the NHS. He is an eligible EU Qualified Person, responsible for supply chain audit oversight and batch release for clinical and commercial products. Eric has worked with a broad range of sterile and non-sterile dosage forms including orphan products as well as time critical sterile and veterinary products. He holds leadership roles in quality, delivering a green field manufacturing facility design project, GMP licence applications and building brand-new quality teams.    

Eric Che

CEO & Co-Founder

Peter Mollison

Peter has over 15 years’ experience in the pharmaceutical industry. Qualifying as a pharmacist in 2004, he worked at the Institute of Cancer Research on pharmacogenomic and drug discovery, before moving into commercial and clinical sterile and non-sterile production roles in the UK NHS and commercial organisations. Since 2009, he has worked in Quality roles covering dosage forms, including radiopharmaceuticals and ATMPs. Gaining QP status in 2014, Peter performed batch release for large and small-scale pharmaceutical EU organisations, before continuing as a consultant, overseeing projects including facility builds, FDA remediation, training and QMS implementation.

Peter Mollison

CEO & Co-Founder

David Cox

Site Director

Nathan Gray

Commercial Director

Jessica Hale

Head of Finance

Lucy Burgess

Head of HR and Governance

More about us

Our Approach

Our Approach

Eramol has developed a profound customer process that aims to deliver complete satisfaction to our clients at every stage.

Know More
Company

Company

The company is privately owned. As a private equity-free company, Eramol is able to act in the best interests of the Company and its Clients, with a focus on service, delivery and innovation.

Know More
Accreditations

Accreditations

Eramol is an authorised organisation across many strategic areas of the business. Accreditations relate to MHRA, HPRA, MHRA GDP and WDA(v). We work with all relevant bodies to ensure the very latest accreditations in line with ongoing, continuous developments in the industry.

Know More